About TruTrace Technologies Inc
TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. TruTrace’s technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis.
TruTrace’s technology is proprietary, immutable and cryptographically secure, thereby establishing a single-source, accurate, validated and permanent account for cannabis strains from ownership to market.
Our Buzz on the Street videos covering TruTrace Technologies Inc. (OTC: BKKSF) (TSX-V: TTT) latest corporate News
Each transaction in the supply chain is authenticated and properly identified
Establishes unchanged Integrity of products to
Automatic execution of contracts lead to rapid transactions at a global scale
All participants see a uniform view of data, updated in
Strainsecure Offers Multiple Registration Types
May 16, 2019 - TruTrace Technologies and California-based Nonnie's Nectar Execute Letter of Intent to Begin Product Validation Program
TruTrace Technologies Inc. (TSXV: TTT; OTC: BKKSF) (“TruTrace” or the “Company”), creator of the first blockchain-enabled fully-integrated IP tracking platform for the cannabis industry, today announced it has entered into a letter of intent dated May 15, 2019 with Nonnie’s Nectar, LLC, a Los Angeles-based hemp extract company that produces premium full-spectrum hemp-based products grown in the U.S.A. using organic farming practices, to employ the StrainSecure™ platform to collect, register, manage, track and publish verified testing data of several of their products in the market.
Under this arrangement TruTrace will produce a unique quick-response (QR) code for each associated SKU, which will then render real-time test results of each product on StrainSecure’s hosted solution. Customers will be given dynamic information on the products they are holding in their hands while still in the store. Upon completion of the collection and registration of the products, Nonnie’s Nectar will then be able to guarantee the contents, origin and quality of their products. The LOI will be superseded by a formal agreement and the transactions contemplated therein are subject to the approval of the TSX Venture Exchange.
“Our step forward with Nonnie’s Nectar is an illustration of the growing traction that our proprietary software is gaining, and the value of secure and verified testing data for this growing industry. Companies throughout the hemp and cannabis industries are recognizing the inherent and significant value in protecting and publishing the quality of their crafted products,” said TruTrace Technologies Chief Executive Officer and Director, Robert Galarza. “With our unique technology, Nonnie’s Nectar will soon be able to guarantee the safety and potency of their full-spectrum hemp extract products and support their mission of creating the highest quality extracts with no solvents, heavy metals or pesticides.”
“TruTrace Technologies will enable us to guarantee that our products contents, purity and potency are exactly as labelled, providing our customers with level assuredness about our dedication to quality control,” said Ryan Beers, Chief Executive Officer of Nonnie’s Nectar.
See full news release here: https://www.newswire.ca/news-releases/trutrace-technologies-and-california-based-nonnie-s-nectar-execute-letter-of-intent-to-begin-product-validation-program-872615649.html
May 9, 2019 - TruTrace Technologies and Canadian laboratory services company Molecular Science Corp enter into Strategic Working Relationship
TruTrace Technologies Inc. (TSXV: TTT; OTC: BKKSF) (“TruTrace” or the “Company”) today announced that it has entered into a letter of intent dated April 30, 2019 (the “LOI”) with Molecular Science Corp. (“MSC”). Under the terms of the LOI, the parties will work together to explore opportunities to combine the blockchain-secured technology of TruTrace with the analytical expertise of MSC in order to deliver greater transparency and visibility around the quality of products being offered in the legal cannabis industry.
“Working with MSC marks a significant step forward for TruTrace in our mission to create a true testing benchmark for the Canadian cannabis market. Its comprehensive process of analytical testing on cannabis and cannabis products, including potency, terpene profiling, pesticide levels, heavy metals content and mycotoxins testing, combined with its commitment to bringing awareness to testing standards, ensures a higher level of quality control for the industry. By combining its services with the StrainSecure™ platform, we anticipate being able to finally create a benchmark for the cannabis industry,” said TruTrace CEO, Robert Galarza.
“MSC’s collaboration with TruTrace represents an important step towards establishing and maintaining world-leading standardization and transparency for cannabis quality control in this rapidly-evolving market. The integration of MSC’s analytical testing expertise with TruTrace’s robust and secure technology platform is an opportunity for both parties to make a significant contribution to this important goal,” said MSC CEO, Christian Carswell.
Terms of the LOI:
Under the terms of the LOI, the parties have agreed that: (a) TruTrace will include MSC. as a preferred partner; and (b) the parties will explore development and integration opportunities to utilize their mutual technologies to bring greater transparency and visibility to the legal cannabis industry. The parties have agreed to negotiate, settle and execute a definitive agreement formalizing their relationship (the “Formal Agreement”) on or before June 30, 2019. Entry into the Formal Agreement, and the closing of the transactions contemplated in it, are subject to certain conditions, including completion of each party’s satisfactory due diligence review of the other.
See full news release here: https://www.newswire.ca/news-releases/trutrace-technologies-and-canadian-laboratory-services-company-molecular-science-corp-enter-into-strategic-working-relationship-870425186.html
May 7, 2019 - TruTrace Technologies enters into Strategic Working Relationship with Strainprint Technologies
TruTrace Technologies Inc. (TSXV: TTT; OTC: BKKSF) (“TruTrace” or the “Company”) today announced that it has entered into a letter of intent dated April 30, 2019 (the “LOI”) with Strainprint™ Technologies Ltd. (“Strainprint”). Under the terms of the LOI, the parties will work together to explore development and integration opportunities to utilize their mutual technologies in order to bring greater transparency and visibility to the legal cannabis industry.
“We’re thrilled to begin working with Strainprint in a greater capacity. What they’ve architected from an education and data standpoint is nothing short of remarkable, and we collectively believe that a synergistic relationship between our software platforms will bring a new level of verification and trust to the efficacy of medical cannabis,” said TruTrace CEO, Robert Galarza. “We look forward to formalizing the details of our working relationship and continuing to update the industry and shareholders as our work continues to evolve.”
“We’re excited to explore combining our award-winning data, analytics and research capabilities with TruTrace’s established and powerful platform. As the leading source of medical cannabis use data, with over 60 million data points from 1.2 million medical cannabis patient reported outcomes, we are uniquely positioned to work alongside TruTrace to help drive standardization, transparency and compliance that will shape the global cannabis industry in a meaningful way,” said Strainprint CEO, Andrew Muroff.
Terms of the LOI:
Under the terms of the LOI, the parties have agreed that: (a) TruTrace will include Strainprint as a preferred partner; and (b) the parties will explore development and integration opportunities to utilize their mutual technologies to bring greater transparency and viability to the legal cannabis industry. The parties have agreed to negotiate, settle and execute a definitive agreement formalizing their relationship (the “Formal Agreement”) on or before June 30, 2019. Entry into the Formal Agreement, and the closing of the transactions contemplated in it, are subject to certain conditions, including completion of each party’s satisfactory due diligence review of the other.
April 24, 2019 - Blockstrain Announces Name Change to TruTrace Technologies
Blockstrain Technology Corp. announces that, further to its News Release dated April 15, 2019, the TSX Venture Exchange has approved the change of name (“Name Change”) of the Company to TruTrace Technologies Inc. The Name Change will become effective at the opening of the market on April 24, 2019 and the company will trade under the new symbol “TTT” on the TSX Venture Exchange.
“We’re excited to continue the strong work we started under this new banner TruTrace Technologies. It is a more accurate reflection of our expanded full service enterprise software solution and better captures the full breadth of our offerings,” said Chief Executive Officer Robert Galarza. “It also better communicates the true extent of the opportunities for our technology that provides value and integrity, not just to the cannabis industry but other industries as well.”
April 15, 2019 - BLOCKStrain Announces Proposed Name Change to TruTrace Technologies Inc.
Blockstrain Technology Corp. announces that, subject to TSX Venture Exchange approval, it will change its name to TruTrace Technologies Inc.
“Evolving from BLOCKStrain to TruTrace Technologies is a reflection of our maturity as a company,” said CEO Robert Galarza. “We have developed an end-to-end enterprise software solution and wanted our branding to capture the full breadth of who we are and what we do.”
“We strongly believe in the value that blockchain provides in areas of security, transparency and intellectual property protection, and it still serves as a core feature of our platform,” says Galarza. “As we continue expanding our cannabis-focused functionality and exploring opportunities in other industries, we can do so with the confidence of a brand name that better communicates what makes us different.”
Over the coming months, the Company’s core platform BLOCKStrain™ will also be transitioning into StrainSecure™ to better showcase the level of security and transparency the Company’s technology provides producers, regulators and consumers.
April 11, 2019 - BLOCKStrain Technology Appoints Dr. Gina Conte as Director of Genetics
BLOCKStrain Technology Corp. (TSX:V: DNAX.V) (OTC: BKKSF) (“BLOCKStrain”), creator of the first Blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, today announced it has appointed award-winning geneticist Dr. Gina Conte to the role of Director of Genetics. Dr. Conte brings an extensive amount of expertise to her role, and will provide leadership and direction in business development.
“Dr. Conte brings significant experience and insight to BLOCKStrain, and will provide tremendous strength to our growing cadre of cannabis-based science experts,” said CEO, Robert Galarza. “Her past research into this field has provided forward momentum and knowledge around the genetics and profiling of cannabis strains, and we are excited to have her as a key part of our team as we work diligently to provide both industry participants and consumers with best-in-class technology solutions.”
“BLOCKStrain’s mission to increase transparency and integrity in the cannabis industry aligns strongly with my ongoing interest and specialization in the genetics of cannabis strains,” said Dr. Conte. “I look forward to working closely with BLOCKStrain as they continue to innovate with this industry-best technology platform.”
Dr. Conte is currently the Chief Scientific Officer at Lighthouse Genomics Inc. where she leads the company in the development and implementation of genomic services for the certification and verification of cannabis strains. Dr. Conte is also Co-founder and Chief Scientific Officer of Illuminate Data Science Inc. where she leads a research program to model the effects of cannabis strains and products on the therapeutic efficacy and experience using innovative machine learning.
In connection with this appointment BLOCKStrain has agreed to grant Dr. Conte stock options to acquire up to 250,000 common shares in the capital of BLOCKStrain, subject to the terms of a stock option agreement to be entered into by the parties.
April 4, 2019 - BLOCKStrain Technology to Present Keynote at MaRS HealthKick Focus Conference
BLOCKStrain Technology Corp. (TSX:V: DNAX.V) (OTC: BKKSF) (“BLOCKStrain”), creator of the first Blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, announced its participation at the upcoming MaRS HealthKick Focus Conference in Toronto on April 4, 2019, where Chief Executive Officer Robert Galarza will present a keynote address.
Mr. Galarza will discuss the role that technology has played in health and wellness and more specifically, the importance of data driven ecosystem to limit disparity and bring cannabis out of the shadows and into the light of modern medicine. He will discuss the challenges that come with bridging a once illicit industry with sophisticated organizations, as well as the unique opportunities that are unfolding for innovators and entrepreneurs to support this evolving industry. From artificial intelligence and augmented reality, to decentralized ledger solutions, Mr. Galarza will discuss the exciting role that data and technology can have in helping the cannabis industry grow in Canada and beyond.
“I’m honoured for the opportunity to address participants – industry leaders and experts in the science, technology and business of cannabis – at the MaRS HealthKick Focus conference,” said Mr Galarza. “BLOCKStrain has been focused on increasing integrity and transparency in the cannabis industry and strongly believe that technological and scientific advances will enable this. We anticipate that our software can play a pivotal role as the industry continues to evolve and move forward.”
The MaRS HealthKick Focus Conference is a gathering of keynotes, panels and lightning talks from industry leaders and experts as they explore what the industry is doing to make new applications a reality.
April 2, 2019 - BLOCKStrain Technology Nominated for Best Software at O'Cannabiz Awards Gala
BLOCKStrain Technology Corp. (TSX:V: DNAX.V) (OTC: BKKSF) (“BLOCKStrain”), creator of the first Blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, announced its software suite has been nominated for “Best Software” at the O’Cannabiz Industry Awards Gala on Thursday, April 25th 2019.
“BLOCKStrain’s mission is to provide Licensed Producers, craft growers, cannabis-product developers and of course, consumers, with a high level of confidence in the quality and contents of their cannabis-based products.” said Chief Executive Officer, Robert Galarza. “We take pride in having developed what we believe is a comprehensive, best-in-class platform and are honoured to be included as a nominee in the category of ‘Best Software’ at this premier event, presented by one of Canada’s most highly-regarded business-to-business cannabis conferences.”
The Gala, which will be held during the O’Cannabiz conference, taking place from April 25 to 27, 2019 in Toronto, is a celebration and exclusive event to recognize the industry’s best professionals and products in 35 categories. Registered voters will only be able to vote once, per email address, during the voting period, which closes at 12:00 p.m. Eastern time (9:00 a.m. Pacific time) on April 3, 2019. Once registered, voter information will be stored in the O’Cannabiz database so users may come back and complete their voting at their leisure (until voting closes on April 03, 2019).
All winners will be announced live at the The O’Cannabiz Industry Awards Gala.